Efficacy of Replication-Defective Adenovirus-Vectored Vaccines: Protection Following Intramuscular Injection Is Linked to Promoter Efficiency in Muscle Representative Cells (Q41076560)

From Wikidata

Jump to navigation Jump to search

scientific article published on November 24, 1997

Language	Label	Description	Also known as
English	Efficacy of Replication-Defective Adenovirus-Vectored Vaccines: Protection Following Intramuscular Injection Is Linked to Promoter Efficiency in Muscle Representative Cells	scientific article published on November 24, 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Efficacy of Replication-Defective Adenovirus-Vectored Vaccines: Protection Following Intramuscular Injection Is Linked to Promoter Efficiency in Muscle Representative Cells (English)

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

author name string

A. Ambriović

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

M. Adam

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

M. Monteil

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

D. Paulin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

M. Eloit

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

24 November 1997

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9400605

28 November 2024

full work available at URL

https://doi.org/10.1006/viro.1997.8842

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9400605

28 November 2024

https://api.elsevier.com/content/article/PII:S0042682297988425?httpAccept=text/xml

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

https://api.elsevier.com/content/article/PII:S0042682297988425?httpAccept=text/plain

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

238

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

327-335

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1099/0022-1317-36-1-59

Cultured human myoblasts and myotubes show markedly different transducibility by replication-defective adenovirus recombinants

1

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Vaccination of pigs with replication-defective adenovirus vectored vaccines: the example of pseudorabies

2

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

The use of DNA viruses as vectors for gene therapy

3

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Cellular promoters incorporated into the adenovirus genome: effects of viral regulatory elements on transcription rates and cell specificity of albumin and beta-globin promoters

4

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Detection of Antibodies to Herpes Simplex Virus with a Continuous Cell Line Expressing Cloned Glycoprotein D

6

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc

7

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus

8

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses

9

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigens

10

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Gene vaccination with naked plasmid DNA: mechanism of CTL priming

11

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

12

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice

13

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo

14

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen

15

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

16

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species

17

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Identification of antigenic sites on pseudorabies virus glycoprotein gp50 implicated in virus penetration of the host cell

18

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Identification of the pseudorabies virus glycoprotein gp50 as a major target of neutralizing antibodies

19

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

20

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Plasmid vectors as anti-viral vaccines

21

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

22

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge

25

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.

26

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection

28

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

cis and trans requirements for the selective packaging of adenovirus type 5 DNA

29

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

The immunobiology of muscle

31

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery

33

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Protection of mice from lethal infection with Aujeszky's disease virus by immunization with purified gVI.

34

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter

35

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors

37

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins

43

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Immunobiology of pseudorabies (Aujeszky's disease)

44

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models

45

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.

46

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV type 1 env and rev gene products

47

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Efficient gene transfer and expression in primary B lymphocytes

48

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Adenovirus as an expression vector in muscle cells in vivo

50

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin

51

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Recombinant adenoviruses as vaccines

52

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants

53

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice

54

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Mammalian cell lines can be efficiently established in vitro upon expression of the SV40 large T antigen driven by a promoter sequence derived from the human vimentin gene

55

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Heterologous protection against influenza by injection of DNA encoding a viral protein

56

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Gene inoculation generates immune responses against human immunodeficiency virus type 1

57

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50

58

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Direct gene transfer into mouse muscle in vivo

59

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Immune responses to nucleic acid vaccines to rabies virus

60

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Investigation of promoter function in human and animal cells infected with human recombinant adenoviruses expressing rotavirus antigen VP7sc

61

1 reference

10.1006/VIRO.1997.8842

https://api.crossref.org/works/10.1006/VIRO.1997.8842

28 November 2024

Identifiers

10.1006/VIRO.1997.8842

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41076560&oldid=2280670680"